FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced Parkinson disease, according to a news release from Supernus Pharmaceuticals.
👉 Full Story
Statins only add 3 DAYS to your life?!?
- Trump’s Housing Sec To Scrap Obama-Era Rule Allowing Men In Women’s Shelters - Hudson Crozier
- Ultimate Guide to AI Voice Recognition - seo
- UK government demands Apple backdoor to encrypted cloud data: report - Carly Page
- SNK’s Fatal Fury will be a new esports game at the Esports World Cup - Dean Takahashi
- Leverage helps game companies build lasting IPs and brands - Dean Takahashi
- 6 people arrested in connection to theft of $60,000 worth of butter
Migrant Rioters DEMAND To Stay In America
- PETA suggests 'weather reveal' cake for Groundhog Day to retire Punxsutawney Phil
- Ultimate Guide to AI Face Recognition - seo
- Researchers discover short form of a tumor-produced protein activates natural killer cells
- Gaza residents stream home to the north after hostage breakthrough - MeighTimbol
- Scientists discover new type of life form living in the human body
- Ultimate Guide to Google Pay: Everything You Need to Know - seo